the second trial , without a concurrent control group , included patients with stage i uterine sarcoma and adjuvant cyclaphosphamide , vincristine , adriamycin , and dacarbazine ( cyvadic ) chemotherapy .
C0042679
vincristine
C0057010
cyvadic